Patents by Inventor Kerri FORD

Kerri FORD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients
    Patent number: 11946939
    Abstract: Provided herein are methods for assessing risk of infection or cardiovascular disease (CVD) in a subject with an inflammatory disease, e.g., rheumatoid arthritis. The methods include performing immunoassays to generate scores based on quantitative data for expression of biomarkers relating to inflammatory biomarkers with or without additional clinical variables to assess infection and CVD risk. Also provided are uses of inflammatory biomarkers for guiding treatment decisions.
    Type: Grant
    Filed: March 15, 2021
    Date of Patent: April 2, 2024
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Kerri Ford, Jeffrey R. Curtis
  • COMPOSITIONS AND METHODS FOR TREATING POLYMYALGIA RHEUMATICA BY ADMINISTERING AN IL-6R ANTAGONIST
    Publication number: 20230399410
    Abstract: The present disclosure relates to the use of an anti-IL6 receptor antibody, or an antigen-binding fragment thereof, for treating polymyalgia rheumatica (PMR).
    Type: Application
    Filed: April 5, 2023
    Publication date: December 14, 2023
    Inventors: Jennifer SLOANE LAZAR, Yong LIN, Wanling WONG, Ying LIU, Frédéric MARRACHE, Kerri FORD, Stefano FIORE, Lita ARAUJO, Danielle ISAMAN, Jeffrey CURTIS, Chad NIVENS, Bola AKINLADE, Angeliki GIANNELOU
  • COMPOSITIONS AND METHODS FOR TREATING NONINFLAMMATORY PAIN IN SUBJECTS WITH RHEUMATOID ARTHRITIS
    Publication number: 20230192871
    Abstract: The present disclosure relates to the use of an anti-IL6 receptor antibody for treating non-inflammatory pain in subjects with rheumatoid arthritis.
    Type: Application
    Filed: May 27, 2021
    Publication date: June 22, 2023
    Inventors: Kerri FORD, Hubert VAN HOOGSTRATEN
  • BIOMARKERS AND METHODS FOR ASSESSING MYOCARDIAL INFARCTION AND SERIOUS INFECTION RISK IN RHEUMATOID ARTHRITIS PATIENTS
    Publication number: 20210199671
    Abstract: Provided herein are methods for assessing risk of infection or cardiovascular disease (CVD) in a subject with an inflammatory disease, e.g., rheumatoid arthritis. The methods include performing immunoassays to generate scores based on quantitative data for expression of biomarkers relating to inflammatory biomarkers with or without additional clinical variables to assess infection and CVD risk. Also provided are uses of inflammatory biomarkers for guiding treatment decisions.
    Type: Application
    Filed: March 15, 2021
    Publication date: July 1, 2021
    Applicants: CRESCENDO BIOSCIENCE, INC., UAB RESEARCH FOUNDATION
    Inventors: Kerri FORD, Jeffrey R. CURTIS
  • Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients
    Patent number: 10962552
    Abstract: Provided herein are methods for assessing risk of infection or cardiovascular disease (CVD) in a subject with an inflammatory disease, e.g., rheumatoid arthritis. The methods include performing immunoassays to generate scores based on quantitative data for expression of biomarkers relating to inflammatory biomarkers with or without additional clinical variables to assess infection and CVD risk. Also provided are uses of inflammatory biomarkers for guiding treatment decisions.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: March 30, 2021
    Assignees: CRESCENDO BIOSCIENCE, INC., UAB RESEARCH FOUNDATION
    Inventors: Kerri Ford, Jeffrey R. Curtis
  • BIOMARKERS AND METHODS FOR ASSESSING MYOCARDIAL INFARCTION AND SERIOUS INFECTION RISK IN RHEUMATOID ARTHRITIS PATIENTS
    Publication number: 20200292559
    Abstract: Provided herein are methods for assessing risk of infection or cardiovascular disease (CVD) in a subject with an inflammatory disease, e.g., rheumatoid arthritis. The methods include performing immunoassays to generate scores based on quantitative data for expression of biomarkers relating to inflammatory biomarkers with or without additional clinical variables to assess infection and CVD risk. Also provided are uses of inflammatory biomarkers for guiding treatment decisions.
    Type: Application
    Filed: March 10, 2020
    Publication date: September 17, 2020
    Applicants: CRESCENDO BIOSCIENCE, INC., UAB RESEARCH FOUNDATION
    Inventors: Kerri FORD, Jeffrey R. CURTIS